Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CASI

CASI Pharmaceuticals (CASI)

CASI Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CASI
DateTimeSourceHeadlineSymbolCompany
15/05/202422:00PR Newswire (US)CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)NASDAQ:CASICASI Pharmaceuticals Inc
15/05/202420:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CASICASI Pharmaceuticals Inc
14/05/202422:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
13/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CASICASI Pharmaceuticals Inc
09/04/202407:00PR Newswire (US)CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTASNASDAQ:CASICASI Pharmaceuticals Inc
28/03/202422:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
05/03/202423:00PR Newswire (US)CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In ChinaNASDAQ:CASICASI Pharmaceuticals Inc
16/02/202423:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINANASDAQ:CASICASI Pharmaceuticals Inc
14/11/202323:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATESNASDAQ:CASICASI Pharmaceuticals Inc
08/11/202323:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPANASDAQ:CASICASI Pharmaceuticals Inc
11/08/202321:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATESNASDAQ:CASICASI Pharmaceuticals Inc
01/08/202321:00PR Newswire (US)Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI PharmaceuticalsNASDAQ:CASICASI Pharmaceuticals Inc
20/07/202322:00PR Newswire (US)CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339NASDAQ:CASICASI Pharmaceuticals Inc
17/05/202321:35PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
26/04/202323:49PR Newswire (US)CASI Pharmaceuticals Files Annual Report on Form 20-F for Fiscal Year 2022NASDAQ:CASICASI Pharmaceuticals Inc
26/04/202322:27Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CASICASI Pharmaceuticals Inc
26/04/202321:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
22/03/202321:04Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CASICASI Pharmaceuticals Inc
22/03/202308:08Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CASICASI Pharmaceuticals Inc
22/03/202307:51Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CASICASI Pharmaceuticals Inc
22/03/202307:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CASICASI Pharmaceuticals Inc
22/03/202307:30PR Newswire (US)CASI PHARMACEUTICALS COMPLETES REDOMICILIATION MERGERNASDAQ:CASICASI Pharmaceuticals Inc
10/02/202302:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CASICASI Pharmaceuticals Inc
02/02/202302:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CASICASI Pharmaceuticals Inc
01/02/202308:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CASICASI Pharmaceuticals Inc
06/01/202323:00PR Newswire (US)CASI PHARMACEUTICALS AND CLEAVE THERAPEUTICS ANNOUNCE CLINICAL TRIAL APPLICATION APPROVAL FOR CB-5339 IN PATIENTS WITH MULTIPLE MYELOMA IN CHINANASDAQ:CASICASI Pharmaceuticals Inc
15/12/202223:00PR Newswire (US)CASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATIONNASDAQ:CASICASI Pharmaceuticals Inc
16/11/202218:57TipRanksBTIG Sticks to Their Buy Rating for CASI Pharmaceuticals (CASI)NASDAQ:CASICASI Pharmaceuticals Inc
15/11/202208:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CASICASI Pharmaceuticals Inc
14/11/202223:00PR Newswire (US)CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTSNASDAQ:CASICASI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CASI